We sequenced all nine exons, exon-intron junctions including a part of introns, 5?-‰anking and 3?-untranslated regions of the cytochrome P450 (CYP) 2A13 gene from 192 Japanese individuals. We found eighteen novel genetic polymorphisms includingˆve single nucleotide polymorphisms (SNP) and one three base pair insertion causing amino acid substitution and one amino acid insertion, respectively, one silent SNP in exon 4, four SNPs in a 5?-‰anking region, and seven SNPs in introns. Theˆve SNPs (74GÀA in exon 1, 579GÀA in exon 2, 1706CÀG in exon 3, and 7343TÀA and 7465CÀT in exon 9) causing amino acid substitutions (Arg 25 Gln, Arg 101
Introduction
Human cytochrome P450 (CYP) 2A6 and CYP2A13 are members of the CYP2A gene subfamily, which are involved in the metabolic activation of tobacco-related carcinogens. Recently, a number of genetic polymorphisms of the CYP2A6 and the CYP2A13 genes were reported. [1] [2] [3] In the present study, we sequenced all nine exons, exon-intron junctions including a part of introns, 5?-‰anking region (5?-FR), and 3?-untranslated region of the CYP2A13 gene from 192 Japanese subjects, and identiˆedˆve novel SNPs and one three base pair insertion causing amino acid substitutions and one amino acid insertion, respectively, one silent SNP in exon 4, four SNPs in a 5?-FR, and seven SNPs in introns.
Materials and Methods
Detailed information on the Japanese subjects was described previously. 4) Informed consent was obtained from every volunteer. This study was approved by the ethics committee of Hokkaido University. The sequence of the complete human CYP2A13 gene described in the GenBank (accession number NGä000008) was used as a reference. The primers used for speciˆc ampliˆcation of each region of the CYP2A13 gene are shown in Table 1 . Table 1 . Sequences were determined using ABI PRISM 3100 sequencer (Perkin Elmer, Foster City, CA, USA). We estimated haplotype phasing by SNPAlyze } (DYNACOM, Chiba, Japan) and HAP (http://‰uŠ.cs.columbia.edu:8080 W hap W ).
Results and Discussion
We found the following eighteen novel polymor The other sequences of the ampliˆed fragments were identical to the CYP2A13 sequence described in the GenBank. The nucleotide changes and the frequencies of newly identiˆed variants are summarized in Cys substitutions and 133ä134 Thr insertion, respectively (Fig. 1) . The mutations of 74GÀA, 579GÀA, 1706CÀG, 7343TÀA, 7465CÀT, and 1634ä1635 ACC insertion were found at the frequencies of 7.3z, 0.3z, 4.9z, 0.3z, 1.0z, and 4.9z in the present study. Figure 2 shows the sequences of the CYP2A13 gene containing the novel mutations which were obtained from only one subject. These sequences were determined for both strands. We also found additional ten SNPs, which were already reported. Analysis of the distribution of all variants, which were found in the present study, allowed the identiˆcation of fourteen CYP2A13 alleles, namely CYP2A13 * 1A-CYP2A13 * 1H, CYP2A13 * 2A, CYP2A13*2B, CYP2A13*3-CYP2A13*6 ( Table 2) . Since theˆve novel SNPs and one three base pair insertion are located in exons of the CYP2A13 gene with amino acid substitutions and insertion, these nucleotide changes are expected to alter the catalytic properties of the CYP2A13.
